A Phase 3 interventional study of Transdermal glyceryl trinitrate 10mg patches and Placebo patches in Radial Artery Spasm, sponsored by 424 General Military Hospital. Status unknown at 1 site in Greece. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2021-02-23.
Sponsored by 424 General Military Hospital · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Transradial cardiac catheterization and percutaneous coronary intervention are increasingly being performed worldwide in elective and emergency procedures, with many centres adopting the transradial route as their first choice of arterial access. One of the most common complications encountered during transradial procedures is radial artery spasm. The aim of this study is to evaluate the Efficacy and Safety of the use of transdermal Glyceryl trinitrate patches applied to skin before cardiac catheterization to prevent the occurrence of radial artery spasm during transradial access cardiac catheterization.
123 studies on the registry are indexed under Spasm; 7 are open to participants now.
This study's planned enrollment of 150 is above the median of 80 across 104 interventional studies indexed under Spasm.
Browse Spasm studies →424 General Military Hospital is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Transdermal glyceryl trinitrate 10mg patches
Drug: Placebo patches
Transdermal patches applied to skin 30 minutes before cardiac catheterization
Also known as: Nitrong tts 10mg- Lavipharm S.A.
Transdermal placebo patches applied to skin 30 minutes before cardiac catheterization
Radial Spasm occurrence
Radial spasm is measured by the exerting force (in Newton) removing the sheath from the patient
Time frame: Immediately after the end of the procedure
Successful radial puncture
The success is defined by the fast radial puncture and catheterization and is measured by the time of radial catheterization
Time frame: During radial puncture and catheterization
VRS-4 pain scale
The pain during the procedure is measured by the four-category verbal rating scale (VRS-4)
Time frame: During the whole procedure
State-Trait Anxiety Inventory (STAI)
The anxiety during the procedure is measured by the State - Trait Anxiety Inventory (STAI)
Time frame: During the whole procedure
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2021 (actual). Primary completion is estimated for Dec 2021, 11 months after the start.
Of 11 phase 3 interventional studies under Spasm, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 12. This study's planned 11 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Nitroglycerin
424 General Military Hospital